Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience-Reference-Cited by-同舟云学术

Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience

Published:2021-08 Issue:8 Volume:21 Page:549-557
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Eşkazan Ahmet Emre,Özmen Deniz,Öztaş Mert,Bektaş Fatih,Bayraktar Eşref Alperen,Sadri Sevil,Keskin Dilek,Özgür Yurttaş Nurgül,Elverdi Tuğrul,Salihoğlu Ayşe,Ar Muhlis Cem,Öngören Şeniz,Başlar Zafer,Aydın Yıldız,Soysal Teoman

Funder

Novartis

Bristol-Myers Squibb

Pfizer

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference23 articles.

1. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European countries;Hoffmann;Leukemia,2015

2. Tyrosine kinase inhibitor sequencing in patients with chronic myeloid leukemia;Tiribelli;Oncol Ther,2019

3. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population;Bower;J Clin Oncol,2016

4. Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events - is better always good?;Eskazan;Expert Rev Hematol,2017

5. Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study;Sánchez-Guijo;Leuk Res,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights;Cells;2023-06-23

2. The Effect of Comorbidities on the Choice of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia;International Journal of Hematologic Oncology;2022-03

3. Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting;Expert Review of Hematology;2022-02-01

4. Measuring prognosis in chronic myeloid leukemia: what’s new?;Expert Review of Hematology;2021-06-03

5. A clinical appraisal of chronic myeloid leukaemia (CML)‐related death and CML‐specific death—Are they synonymous?;International Journal of Clinical Practice;2021-05-17